These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
353 related articles for article (PubMed ID: 16024790)
1. NF-kappa B-mediated MyoD decay during muscle wasting requires nitric oxide synthase mRNA stabilization, HuR protein, and nitric oxide release. Di Marco S; Mazroui R; Dallaire P; Chittur S; Tenenbaum SA; Radzioch D; Marette A; Gallouzi IE Mol Cell Biol; 2005 Aug; 25(15):6533-45. PubMed ID: 16024790 [TBL] [Abstract][Full Text] [Related]
2. NF-kappaB stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis. Hatano E; Bennett BL; Manning AM; Qian T; Lemasters JJ; Brenner DA Gastroenterology; 2001 Apr; 120(5):1251-62. PubMed ID: 11266388 [TBL] [Abstract][Full Text] [Related]
3. Role of nuclear factor kappa B in cytokine-induced nitric oxide and tetrahydrobiopterin synthesis in rat neonatal cardiac myocytes. Hattori Y; Nakanishi N; Kasai K J Mol Cell Cardiol; 1997 Jun; 29(6):1585-92. PubMed ID: 9220344 [TBL] [Abstract][Full Text] [Related]
4. Post-transcriptional regulation of the human inducible nitric oxide synthase (iNOS) expression by the cytosolic poly(A)-binding protein (PABP). Casper I; Nowag S; Koch K; Hubrich T; Bollmann F; Henke J; Schmitz K; Kleinert H; Pautz A Nitric Oxide; 2013 Sep; 33():6-17. PubMed ID: 23711718 [TBL] [Abstract][Full Text] [Related]
5. c-Jun NH2-terminal kinase inhibitor anthra(1,9-cd)pyrazol-6(2H)-one reduces inducible nitric-oxide synthase expression by destabilizing mRNA in activated macrophages. Lahti A; Jalonen U; Kankaanranta H; Moilanen E Mol Pharmacol; 2003 Aug; 64(2):308-15. PubMed ID: 12869635 [TBL] [Abstract][Full Text] [Related]
6. NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Guttridge DC; Mayo MW; Madrid LV; Wang CY; Baldwin AS Science; 2000 Sep; 289(5488):2363-6. PubMed ID: 11009425 [TBL] [Abstract][Full Text] [Related]
7. Role of nuclear factor-kappaB activation in cytokine- and sphingomyelinase-stimulated inducible nitric oxide synthase gene expression in vascular smooth muscle cells. Katsuyama K; Shichiri M; Marumo F; Hirata Y Endocrinology; 1998 Nov; 139(11):4506-12. PubMed ID: 9794459 [TBL] [Abstract][Full Text] [Related]
9. Nitric oxide and tumor necrosis factor-alpha production by oleanolic acid via nuclear factor-kappaB activation in macrophages. Choi CY; You HJ; Jeong HG Biochem Biophys Res Commun; 2001 Oct; 288(1):49-55. PubMed ID: 11594750 [TBL] [Abstract][Full Text] [Related]
10. Acetaminophen inhibits iNOS gene expression in RAW 264.7 macrophages: differential regulation of NF-kappaB by acetaminophen and salicylates. Ryu YS; Lee JH; Seok JH; Hong JH; Lee YS; Lim JH; Kim YM; Hur GM Biochem Biophys Res Commun; 2000 Jun; 272(3):758-64. PubMed ID: 10860828 [TBL] [Abstract][Full Text] [Related]
11. Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor kappaB. Yu Z; Zhang W; Kone BC Biochem J; 2002 Oct; 367(Pt 1):97-105. PubMed ID: 12057007 [TBL] [Abstract][Full Text] [Related]
12. Requirement for endogenous heat shock factor 1 in inducible nitric oxide synthase induction in murine microglia. Huang C; Lu X; Tong L; Wang J; Zhang W; Jiang B; Yang R J Neuroinflammation; 2015 Oct; 12():189. PubMed ID: 26467650 [TBL] [Abstract][Full Text] [Related]
13. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation. Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D J Immunol; 1999 Apr; 162(8):4685-96. PubMed ID: 10202009 [TBL] [Abstract][Full Text] [Related]
15. Induction of expression of inducible nitric oxide synthase by Taxol in murine macrophage cells. Kim YM; Paik SG Biochem Biophys Res Commun; 2005 Jan; 326(2):410-6. PubMed ID: 15582593 [TBL] [Abstract][Full Text] [Related]
16. Regulation by cytokines of the inducible nitric oxide synthase promoter in insulin-producing cells. Darville MI; Eizirik DL Diabetologia; 1998 Sep; 41(9):1101-8. PubMed ID: 9754830 [TBL] [Abstract][Full Text] [Related]
17. Involvement of KSRP in the post-transcriptional regulation of human iNOS expression-complex interplay of KSRP with TTP and HuR. Linker K; Pautz A; Fechir M; Hubrich T; Greeve J; Kleinert H Nucleic Acids Res; 2005; 33(15):4813-27. PubMed ID: 16126846 [TBL] [Abstract][Full Text] [Related]
18. Interaction of interferon regulatory factor-1 and nuclear factor kappaB during activation of inducible nitric oxide synthase transcription. Saura M; Zaragoza C; Bao C; McMillan A; Lowenstein CJ J Mol Biol; 1999 Jun; 289(3):459-71. PubMed ID: 10356322 [TBL] [Abstract][Full Text] [Related]
20. Catalase induces the expression of inducible nitric oxide synthase through activation of NF-kappaB and PI3K signaling pathway in Raw 264.7 cells. Jang BC; Paik JH; Kim SP; Bae JH; Mun KC; Song DK; Cho CH; Shin DH; Kwon TK; Park JW; Park JG; Baek WK; Suh MH; Lee SH; Baek SH; Lee IS; Suh SI Biochem Pharmacol; 2004 Dec; 68(11):2167-76. PubMed ID: 15498507 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]